                                                                                                                                                                       REVIEW
Bacteriophage 2:1, 5â€“14; January/February/March 2012;           G   2012 Landes Bioscience



                                                           Recombineering
             powerful tool modification bacteriophage
                                 genomes
                                              Laura J. Marinelli,1 Graham F. Hatfull2 Mariana Piuri3,*
1
 Department Medicine; Dermatology Division; David Geffen School Medicine; University California Los Angeles; Los Angeles, CA USA; 2Department Biological Sciences;
University Pittsburgh; Pittsburgh, PA USA; 3Departamento QuÃ­mica BiolÃ³gica; Facultad Ciencias Exactas y Naturales; Universidad Buenos Aires; Buenos Aires, Argentina


                                                      Keywords: bacteriophage, recombineering, BRED


     Recombineering, recently developed technique efficient                            contrast range tools described      genetic manipulation bacteria, facilitated phage-                           targeted mutagenesis bacterial chromosomes, fewer methods
     derived recombination proteins advantage                              implemented targeted mutagenesis lytically
     using DNA substrates short regions homology.                            growing phages, high frequency events required      developed E. coli                             absence selectable 



Â© 2012 Landes Bioscience.
     adapted use bacteria. widely used                           Historically, construction mutations bacteriophages      number different systems variety purposes,                       accomplished general mutagenesis using UV irradiation      construction chromosomal gene knockouts, deletions,                               chemical compounds generate DNA damage.
     insertions, point mutations, vivo cloning,                                homologous recombination approach used      mutagenesis bacterial artificial chromosomes                                                                                           make gene deletions recombinant phages,4,5 frequency
     phasmids, construction genomic libraries      reported.  methods                                                                                           low screening desired mutant tedious



                            distribute.
     effectively applied genetic modification                                   time consuming.
     bacteriophage genomes, prophage lytically                             Recently, new vivo technology introduce genetic
     growing states. growing collection fully sequenced                       changes bacterial genomes developed.      bacteriophages raises questions answer,                               techniqueâ€”named â€œrecombineeringâ€?â€”refers engineering
     including unknown functions vast numbers genes                             recombinant DNA homologous recombination.6-8 Recom-
     known homologs unknown function.                                      bineering employs recombination systems encoded bacterio-
     Recombineering phage genomes central addressing                             phages enhance frequency homologous recombination,
     questions, enabling simple construction mutants,                        allowing construction chromosomal gene knock outs,
     determination gene essentiality, elucidation gene                          deletions, insertions, point mutations, vivo cloning, mutagen-
     function. turn, advances understanding phage
                                                                                          esis bacterial artificial chromosomes, phasmids genomic
     genomics present similar recombineering tools      dissecting multitude genetically naÃ¯ve bacterial
                                                                                          libraries.6-15
     systems.                                                                                increased availability bacterial genome sequences                                                                                           facilitated use recombineering, possible                                                                                           recombineer organism sequence known.
                                                                                             systems described employed recombination functions
                                 Introduction                                             encoded bacteriophage lambda Rac prophage,                                                                                           originally designed modification E. coli. Subsequently,
Bacteriophages extremely abundant, estimated                          successfully employed Gram-negative bacteria, number phage particles biosphere approxi-                           Salmonella Shigella,16,17 adapted mately 1031.1 phages source high genetic diversity                         application divergent bacteria, like insect replete genetic novelty.2 played key roles                         endosymbiont Sodalis glossinidius promising subject development bacterial genetics provide effective                        biotechnological exploitation, Pantoea ananatis.18,19
solutions development systems manipulate genetically                           Double-stranded DNA recombineering E. coli using naÃ¯ve bacteria.3 Genetic modification phages facilitate                        lambda Red involves phage-encoded proteins, Exo,
study viruses  consequence, development                            Beta Gam. Exo exonuclease degrades strand
new tools bacterial manipulation.                                                     DNA double-stranded end generate ssDNA
                                                                                          substrate. Beta DNA pairing enzyme anneals                                                                                           recombineering substrate chromosomal target. Gam inhibits
    *Correspondence  Mariana Piuri; Email: mpiuri@qb.fcen.uba.ar
                                                                                          E.coli RecBCD SbcD enzymes, preventing degradation     Submitted: 10/14/11; Revised: 11/15/11; Accepted: 11/16/11                            double-stranded DNA (dsDNA) substrate.20-23 optimal
    http://dx.doi.org/10.4161/bact.18778                                                  dsDNA recombineering, RecBCD inactivated, 

www.landesbioscience.com                                                       Bacteriophage                                                                                  5
 mutation lambda gam.6,8,24 original model proposed            facilitating construction gene-knockouts point degradation Exo, 3' single stranded DNA tail           mutations hard manipulate pathogenic bacterium
exposed Beta bind.8 Homologous recombination                 Mycobacterium tuberculosis, fast-growing related occurs, following strand invasion DNA annealing               species like Mycobacterium smegmatis, routinely use model.25-28 Recently, new model explain mechanism             model 46,47
dsDNA recombination mediated lambda phage proteins                    Mycobacterial strains constructed recombineering contain proposed.29,30 alternative model, lambda exonuclease         extra chromosomal plasmid phage recombina-
entirely degrades strand, leaving strand              tion genes control inducible acetamidase
intact single-stranded DNA. single-stranded intermediate          promoter.48 Similar shown E. coli, dsDNA recombines Î² recombinase catalyzed annealing              recombineering mycobacteria requires exonuclease
replication fork.                                                         (gp60) associated recombinase (gp61),39 recom-
   Rac prophage encodes RecE RecT,                 bination using ssDNA substrates requires recombinase.47
functionally equivalent lambda Exo Beta, respectively.12,31        Targeted gene replacement mutants engineered using linear
   Beta belongs large family ssDNA annealing proteins             dsDNA allelic exchange substrates (AESs), containing regions (SSAPs),32-34 protein necessary single-stranded      homology upstream downstream target gene flanking
oligonucleotide recombination,7 used creation point            cassette antibiotic resistance, electroporated mutations deletions. strand bias recombination levels            M. smegmatis M. tuberculosis recombineering strains.39 observed comparing complementary ssDNAs.                Substrates ssDNA recombineering short oligonucleo-
Higher frequencies obtained using oligonucleotide             tides minimum length 50 bases recommendedâ€”



Â© 2012 Landes Bioscience. anneals DNA strand undergoing discontinuous                   encoding desired mutation, technique provides synthesis (lagging strand). result replication process,       simple efficient method constructing point mutations
transient regions ssDNA accessible Beta-mediated            mycobacterial genomes.47 overall efficiency ssDNA
annealing oligo. increased recombination efficiency            recombineering substantially higher dsDNA sub- â€˜â€˜lagging strandâ€™â€™ oligos reflect increased availability   strates chromosomal plasmid targets.  single-stranded regions lagging vs. leading strand              optimal efficiencies obtained using oligonucleo-



                       distribute.
synthesis.7,12,35                                                         tides target, anneal  DNA strand undergoing
   Regulated expression bacteriophage recombination                discontinuous synthesis (lagging strand template).47 typically required recombineering. functions          display efficiencies 10,000-fold higher integrated chromosome contained              oligonucleotides targeting leading strand, far exceeds
extrachromosomal plasmid. lambda lysogen defective               2â€“50 fold strand biases observed l Red 7,35 prophage used express Red proteins strong          clear biases larger mycobacteria
lambda pL promoter.6 recombineering functions               E. coli, reflect fundamental differences transferred variety different plasmids,36 including          DNA replication systems gp61 interacts
constructs functions control                replication machinery supports necessity arabinose promoter pBAD.14 plasmids carry temperature-             finding recombineering systems specific bacteria sensitive (ts) origin replication, cured       related bacterial group.
cell recombination. prophage constructs contain                Recombineering systems based mycobacteriophage
ts cI857 allele phage lambda repressor allowing protein            Che9c-encoded proteins provided new approaches myco-
expression controlled temperature. low temperature            bacterial mutagenesis greatly expanded genetic toolbox
(30Â°C), recombineering functions strongly repressed,              available study pathogenic mycobacteria.
expression occurs shift 42Â°C 15 min.                     Datta et al.37 identified characterized genes    efficiency recombineering E. coli possibility        similar Beta RecT Gram-positive Gram- using DNA segments short regions homology (approx.             negative bacteria phages. genes, including Che9c
50 bp) target sequences led search proteins         gp61, expressed E. coli control lambda pL, similarity lambda/Rac encoded proteins               protein activity assayed using oligo recombination
phages bacteria, especially adapting lambda/Rac            49 Seven genes adjacent known systems use organisms, particularly       putative exonuclease gene. E. coli  ssDNA
Gram-positive optimal results.37-39                        binding proteins tested able catalyze oligo-mediated
   complete genome sequences 80 mycobacter-              recombination variable efficiency; Che9c gp61 recomb-
iophage genomes40-45 provided thousands unique             ination levels approximately 1000-fold lower genes, making ideal reservoir search novel        observed lambda Î². present canonical
recombineering functions. Recently, RecE RecT homologsâ€”               exonucleases, recombinase-exonuclease pairs products genes 60 61, respectively identified          tested able carry low level recombination mycobacteriophage Che9c, expression substantially            linear dsDNA, coupled lambda Exo; presumably
enhances mycobacterial recombination frequencies. pro-              physical specific coupling required teins utilized develop efficient recombineering           cognate exonuclease single strand annealing proteins. 


6                                                                Bacteriophage                                               Volume 2 Issue 1
 exonuclease species-specific,         engineering lytically growing phages. recombinase function diverse hosts.                             applicable phages propagated    failure observe lambda Red-mediated recombination       laboratory avoids need genetic selection Pseudomonas syringae, based hypothesis recom-          associated problems genetic polarity. main approaches
binases  associated  particular species         recombineering lytically growing phages described, likely function close relatives distantly           using phage lambda model  second using
species,32,50,51 Swingle et al.38used combination bioinformatic   mycobacteriophages model 
tools identify proteins homologous RecE/RecT Pseudomas           method engineering phage lambda originally
syringae pv syringae B728a. called recTEPSY genes           described Oppenheim et al.58-60 general, involves
located 72 kb region horizontally acquired       infecting cells phage, preparing competent cells, introducing
Pseudomas syringae pv syringae B728a. region contains 86          dsDNA ssDNA substrates electroporation analyzing
annotated open reading frames (ORFs), majority            resulting plaques presence mutation. scheme
encode hypothetical proteins. Thirteen ORFs locus          general strategy used modify phages infecting E. coli
annotated phage-related proteins, likely region      shown Figure 1. method relies physical
corresponds prophage remnant prophage containing        screening identify desired mutants, critical recombination functions. Depending oligo concentra-         recombination frequency high, electro-
tion, 450-fold difference recombination frequency           poration efficiency high  true E. coli), RecTPSY expression vector control strains          high proportion cells dsDNA ssDNA
observed. Additionally, dsDNA recombination observed               substrate.



Â© 2012 Landes Bioscience. RecTPSY assisted RecEPSY.                                     strains carrying defective lamboid
   Recombineering used target bacterial chromo-          prophage expressing Î², exo gam W3110 MG1655 extrachromosomal replicating molecules. corollary      derivatives, prophage moved backgrounds  extended efficient straightforward        P1 transduction,6,61,62 desired strain transformed
modification bacteriophage genomes.  discuss       plasmid expressing recombination functions.36 generation E. coli phage mutants using recombineering          reason, modifications, protocol originally deve-



                      distribute.
lambda Red proteins, construction mycobacter-        loped lambda phage, adapted make mutations iophage mutants using BRED (Bacteriophage Recombineering            E. coli phages. Alternatively, intact prophage serve Electroporated DNA).52                                                 source recombination functions target                                                                        recombineering. case, recombination
                Recombineering Prophages                               functions present, prophage inducible                                                                        order recover phage particles recombineering. relatively straightforward approach engineering phage              cases, cells grown exponential phase. lytically
genomes use dsDNA recombineering modify integrated         growing phage going modified, cells infected prophage, effectively treating chromosomal locus.      multiplicity infection (MOI) 1â€“3 left standing allow   limitations disadvantages.       phage adsorb (adsorption conditions phage approach restricted temperate phages.        taken consideration step). necessary useful inducible phages, lytically growing   phage present prophage cells.
particles constructed mutant generated.       step, expression Beta, Exo Gam  concern characterized systems phage       present) induced short period time. Conditions lambda, generally  Second, approach typically        induction determined basis selected
requires use selectable marker recover desired         strain (temperature shift, addition inducer, ). cells
mutant, introduction marker drug resistance         gently washed, appropriate DNA substrate gene introduce genetic polarity, increase size     introduced electroporation. modifying intact pro- phage genome packaging limit. effects        phage, induction time used prophage
minimized using second event using site-specific       going induced recombinant lysate prepared. recombination remove selectable marker,           progeny phage screened mutation. Alter-
requires multiple sequential manipulations. Strategies modify       natively, prophage targeted using selectable marker, integrated prophage described              drug resistance cassette, recombinant bacterial
                                                                       colonies identified using selection  .
             Recombineering E. coli Phages                                single-stranded oligo dsDNA PCR product used
                                                                       substrate bacteriophage recombineering (Fig. 2). E. coli phage mutants played key roles study            ssDNA substrate used  base substitution small deletions
phage biology,53-57 construction screening       insertions), typically 70 bases length desired mutation tedious time consuming. Recom-             designed alteration introduced contained bineering simplified mutant phage construction, increas-        center oligo. 80-nucleotide oligo successfully
ing frequency recombination events cell, enabling        used generate 326 bp deletion cII gene lambda.60 

www.landesbioscience.com                                       Bacteriophage                                                                7
 Â© 2012 Landes Bioscience.
                           distribute.
    Figure 1. E. coli phage recombineering. Schematic representation strategy used construct screen phage mutants recombineering E.
    coli. phage modified present prophage genome, cells infected phage; subsequently, recombination
    functions expressed, cells electrocompetent. substrate introduced infected cells electroporation (dsDNA, ssDNA
    containing deletion D, point mutation *), cultures recovered allow phage assembly. recombinant lysate screened     desired mutant. Plating properties recombinant lysate compared control lysate obtained using protocol     addition substrate. double-layer bacterial lawn technique used strain supports amplification mutant phage      replicate isogenic strain) available. Alternatively, desired mutant screened plaque hybridization using probe     hybridize mutant wt phage. mutant phage identified purified, stock prepared, presence     desired mutation corroborated PCR DNA sequencing.



contrast seen oligo-mediated recombina-                      cleave plasmid purified Dam+ host) tion bacteria, complementary oligos equally efficient                 used reduce residual plasmid. promoting recombination, reflecting rolling circle                     Oppenheim et al.60 used precisely replace replication employed phage.                                                rexA rexB genes lambda gene conferring ampicillin
   dsDNA substrate used, PCR product 50 base                      resistance. substrate target lambda chromosome pairs homology  end) target phage chro-                     generated described Figure 2. case, phage lysate mosome created following strategy outlined Figure 2.                     grown electroporation mix used form lysogens    noted drug resistance markers                     naÃ¯ve E. coli. AmpR lysogens selected, replacement used selection going lysogen,                  rexAB genes confirmed PCR.
markers employed lytically replicating phages. Care                       alternative, recombinant lysogens complete taken plasmid utilized template                    prophage (carrying example, drug resistance marker) PCR reaction used generate substrate, residual                  going selected, electroporation mixture spread
plasmid reaction products transform cells effici-                  filter placed plate rich nonselective
ently, generating undesirable background. Digestion PCR                     medium. incubation hours filter transferred
reaction DpnI  cut PCR product                     plate containing selective drug. overnight growth,



8                                                                         Bacteriophage                                                        Volume 2 Issue 1
  Figure 2. Type substrates used phage recombineering.   ssDNA oligos (70 nt) containing small deletion (D) point mutation (*)  center, anneal lagging strand template DNA replication. (B) mutation going constructed prophage,




Â© 2012 Landes Bioscience.
 target gene replaced antibiotic resistance marker (abR). case, primers amplify resistance marker contain 50
 bases homology target gene used generate dsDNA substrate. (C) Schematic representation strategy used  increase homology target PCR. 200 bp substrate obtained 100-mer oligonucleotide 50 bases homology  deletion 72-mers.  C)  blue green rectangles indicate homology regions flanking target gene.


recombinants cells rise colonies, prophages            gel electrophoresis. Finally, lysate corroborated
excised recover mutant phage particles.                                     recombinant phage prepared used studies.



                        distribute.
   lytically propagated phage genome target, recombinant lysate plated direct selection                   Construction Mycobacteriophage Mutants
plaques screening. Preliminarily, dilutions                                 Recombineering
control recombinant lysates plated lawns bacterial indicator compare plating properties lysates              Mycobacteriophagesâ€”viruses infect mycobacteria (Fig. 1). available, selective indicator strain used.           instrumental overcoming challenges  example, amber mutation introduced essential                forming genetic studies human pathogen, M. tuberculosis.
gene, double-layer bacterial lawn technique63 used               formed basis development shuttle phasmids,65
identify phages carry mutation. case, double-               used transposon mutagenesis,66 reporter gene
layer containing different indicator strains utilized plate          delivery,67-69 specialized transduction,70 recombinant lysate. lower layer contains restrictive               construction integration-proficient vectors, enabling stable
host wild-type (wt) phage multiply,                 introduction foreign genes bacterium.42,43,71-73  layer contains suppressor strain supports growth                  mycobacteriophages instrumental mutant wt phage. Amber mutants lyse                  development techniques mycobacterial mutant construc-
suppressor strain form â€œcloudyâ€? plaques                   tion, genetic tools enabling mutagenesis phages non-suppresor strain grow confluence (Fig. 1).                          lacking.
   phage mutants selected distinguished visually,               general, constructing mutant derivatives bacteriophages
plaque hybridization assay used detect mutant phage              challenging manipulating bacterial host
derivatives (Fig. 1). order identify mutant,              chromosome, antibiotic selection useful 15 bp DNA sequence present recombinant phage,                   lytically propagated viruses. circumvent  mycobacterial original phage, needed use target            recombineering employed manipulation probe.5 corroborate presence desired mutation,                prophages, integrated host chromosome, isolated plaque resuspended buffer used directly              manner similar described manipulation lambda template PCR reaction, using primers flank                 prophages  Unfortunately, relatively mycobacterio-
deletion/insertion.15,52 amplicon differential size expected          phages form stable lysogens, significantly limiting use mutant compared parent phage. MAMA-PCR                      strategy. recently, powerful method manip-
(mismatch amplification mutation assay PCR) used                ulating lytic mycobacteriophages use shuttle
screen point mutations.64 point mutation alters                phasmids74â€”phage-plasmid hybrids packaged restriction site generated, base change identified              phage l particles propagated E. coli. example, restriction amplified PCR product visualization               strategy used make defined mutations tape measure



www.landesbioscience.com                                              Bacteriophage                                                                          9
 gene shuttle phasmid derivative mycobacteriophage TM4 performing mutagenesis E. coli  l Red recombineer-
ing) recovering mutant phage M. smegmatis.15 spite  obvious advantages technique, use mycobacteriophage phasmids remains limited.   multiple steps required construct phasmids, primarily function relatively small packaging
capacity  ~50 kb) l capsids, compared large average size mycobacteriophage genomes (~70 kb).40,41  mycobacteriophage genomes large shuttle
phasmid construction, approach broadly applicable functional genomic studies phage population.
   contrast, mycobacterial recombineering systems offer new, potentially powerful approach constructing mutants lytically growing mycobacteriophage, using method termed
Bacteriophage Recombineering Electroporated DNA (BRED),52 general scheme illustrated Figure 3. critical
aspect technique based observation  mycobacteria, recombineering frequencies appear primarily



Â© 2012 Landes Bioscience.
limited relatively poor DNA uptake efficiencies75;  electrocompetent mycobacteria, 1 1000
viable cells productively DNA. presents challenge constructing mutations selection, chromosomal point mutations known
phenotype, 99.9  colonies recovered arise cells 


                      distribute. unable recombineering substrate.47 issue circumvented ssDNA recombineering employing counter-selection strategy, selectable plasmid  second oligonucleotide incorporates selectable point
mutation) transformed ssDNA substrate.6,7 effectively selects non-competent cells population, transformants screened mutation
using MAMA-PCR,10,64 selectively amplifies mutant
allele. way, non-selectable mutations easily
recovered high efficiency ssDNA recombineering.
   technique described previous section recom-
bineering E. coli phage, l, involves infecting phage targeted, inducing recombineering func-
tions, electroporating DNA substrate;60  inefficiency DNA uptake mycobacteria precludes approach.  BRED, adopted alternative
approach derived selection methods described 52 procedure, M. smegmatis strain carrying recombineering plasmid induced acetamide, electro-
competent cells prepared. electroporation performed
                                                                         Figure 3. Mycobacteriophage recombineering. Schematic representation genomic DNA phage manipulated             strategy used construct phage mutants Mycobacterium PCR-generated synthetic DNA substrate targets             smegmatis recombineering. M. smegmatis cells inducibly expressing
phage (Fig. 2). brief recovery period, reactions         recombination functions electroporated phage DNA mixed additional plating cells M. smegmatis plated        recombineering substrate; mixed M. smegmatis infectious center assay  e., prior lysis, plaques     plating cells plated obtain individual plaques. Primary plaques                                                                          screened PCR flanking primers detect containing generated infected cells, viral particles).    mutant phage present frequency combination way, cells taken phage DNA rise           wt phage. identified way, positive plaque containing plaques bacterial lawn, effectively selecting         mutant allele diluted plated. non-essential gene non-transformable; average, 100 plaques          targeted, mutant phage easily identified PCR. Essentiality obtained 50â€“100 ng phage DNA                      target gene inferred mutant allele detected                                                                          lysate pooled secondary plaques.
experiment. primary plaques contain wild-type


10                                                              Bacteriophage                                                       Volume 2 Issue 1
 phage DNA, subset (5â€“50 ) contain mutant mismatch,  stringent conditions, allele,52 readily identified PCR screening. wild-type allele amplified.
Provided mutation does ablate region essential       application BRED DADA-PCR detec-
phage growth, purified mutant phage derivatives isolated tion strategy quite useful deletion genes plating serial dilutions mixed plaques, followed essential suspected essential phage growth.
purification PCR analysis resulting secondary plaques. able delete number essential genes frequency pure mutants recovered mycobacteriophage Giles  lysin 52 (Hatfull lab,
vary significantly depending factors unpublished data) phages constructing comple-
mutant allele present primary plaque phenotype mentation strain M. smegmatis mutant isolation, mutant (e.g., recovered lower frequency expresses phage gene deleted. cases, reduced burst size compared wild-type).  necessary use DADA-PCR detect primary plaques contain-
analysis 12â€“18 secondary plaques sufficient identify ing mutant allele. recovered wild-type
homogenously mutant strain, cases, bacteria, presumably presence wild-type helper
necessary screen secondary plaques pools 5â€“10 order phage primary plaque. plaque recovered, recover mutant. cases, pool containing essentiality inferred mutant allele detected mutant identified, plating necessary completely lysates prepared plating mixed plaques purify mutant. pooling strategy essentially enriches wild-type cells;  individual mutant particles mutation present low levels rise plaques secondary plating. mixed primary
initial primary plaque.                                                 plaque serially diluted plated comple-



Â© 2012 Landes Bioscience.
   date, common application BRED mentation strain. Secondary plaques picked patched construction unmarked gene deletions;  duplicate wild-type complementing bacteria, mutant
technique used efficiently engineer frame inter- phage identified able infect nal deletions, small insertions, point mutations gene replace- kill complementing M. smegmatis. strategy provides ments phage genome, require selection powerful effective way screen gene essentially, allowing mutant recovery52 (Hatfull Lab, unpublished data). determine unique genes 


                       distribute.
constructing deletion insertion mutant, 200 bp dsDNA mycobacteriophages required lytic growth.
substrate, having 100 bp homology flanking region             type genetic manipulation BRED deleted inserted recommended, higher proportion proved successful engineering point mutations, primary plaques contain desired mutant allele using  ssDNA synthetic substrates employed.52 dsDNA vs. ssDNA substrates, larger substrates (200 bp) vs. extensive length dependence analysis performed,
shorter ones (100 bp). Insertions typically screened PCR using primer anneals inserted region anneals 
stream region phage chromosome. deletions,
primers flank deleted region used; mutant allele present primary plaque, produce smaller PCR product easily visible agarose gel. casesâ€”usually mutants somewhat defectiveâ€”mutant
alleles present low frequencies primary
plaques detected flanking primers. situations, adapted MAMA-PCR
strategy described developed technique
termed Deletion Amplification Detection Assay
(DADA) PCR.52 employs DADA-PCR primer anneals new junction created deletion 3' end anneals flanking DNA,  downstream           Figure 4. Deletion Amplification Assay (DADA) PCR. DADA-PCR used specifically DADA-PCR primer designed             detect presence gene deletion allele present low frequency mutant allele, primer anneal perfectly       difficult detect mixed population mutant WT phage.                                                              DADA-PCR primer designed 3â€™ end anneals new junction deletion site  site created joining   created joining DNA ends flanking deleted region. DNA ends flank deleted region),          primer anneals WT allele, creates mismatch (shown â€˜xâ€™ figure) wild-type phage, terminal 3'     high fidelity DNA polymerase synthesize stringent
nucleotides (depending primer design)        PCR conditions.  DADA-PCR primer complementary deletion
base pair DNA template (Fig. 4). high fide-       allele, appropriate   ) stream primer, generate                                                              product mutant allele present.
lity DNA polymerase difficulty synthesizing


www.landesbioscience.com                                          Bacteriophage                                                                 11
 oligonucleotides 71 nt length                          sequenced annotated bacteriophage genomes available
sufficient efficiently recover mutation (Marinelli, unpub-                            NCBI database, revealing genetically diverse popula-
lished data). Based observations mycobacterial                                   tion architecturally mosaic genomes. immense reservoir
ssDNA recombineering47;  possible shorter                                 genetic information created numerous opportunities substrates work  Importantly, nature                           functional genomic studies aimed uncovering novel functions
phage DNA replication, constructing point mutations, oligo-                             phage population.
nucleotides targeting strands used transformed                                 Just Mycobacteriophages  enormous number phage genomic DNA.52 primary                                       predicted open reading frames unknown function secondary plaques screened mutant allele using MAMA-                              make 3,000 phamilies unique
PCR purified using techniques outlined                                    genes having detectable sequence similarity known
   Finally, shown BRED used                                  proteins.41-45,73,80 increasing hunt phage
struction gene replacement mutants phage genome.52                             proteins promote recombination functions mentioned  antibiotic resistance cassettes useful                           particularly driven number bacteriophage genome lytic phages;  numerous applications                                sequences available.50 functions potentially used construction fluorescent reporter phages67-69                                develop species-specific recombineering systems diverse
envisioned desirable insert foreign                               suite organisms.
gene phage genome. fairly strict packaging size                                  Bacteriophage recombineering shown highly
straints exist dsDNA bacteriophages necessitate                               effective approach construction gene deletions, small
inserting gene egfp (enhanced green fluorescent protein)                           insertions, gene replacements, point mutations lytically



Â© 2012 Landes Bioscience. place similarly sized non-essential phage gene.                             replicating phages.52,60 technique  time,
type BRED, use dsDNA substrates, synthesized PCR,                                   allow perform broad functional genomic studies bac- contain cassette choice flanked 100 bp homolog-                               teriophages, potentially revealing new exciting features ous end target gene replaced.                            diverse phage population.
mutations easily detected using primer pair                                  described modification E. coli phages
anneals newly inserted gene anneals                              mycobacteriophages.  slight modifications 


                              distribute. region  downstream phage genome.                                          protocols, providing appropriate recombination
   date, BRED successfully used different                                systems  methods potentially adapted mycobacteriophages52,76-78 (Hatfull Lab, unpublished data),                           use phages. new bacteriophage isolated likely utility approaches mycobacter-                          possible source new recombination proteins. iophage mutagenesis realized. example,                                 purpose, genetic manipulation phages coupling efficient point mutagenesis mycobacterial non-                              useful recombineering perfect ally sense suppressor strains79 provide relatively simple method                          accomplish objective.  bacteriophage recombineering making conditional lethal mutants mycobacteriophage                                   facilitate study orphan genes provide
genomes. possible utilize technique                         insights phage biology, help uncover
manipulation phages infect species mycobacteria                             new valuable instruments manipulation genetically infecting closely related bacteria.                                           naive bacteria.

                                  Perspectives                                                                               Acknowledgments
                                                                                             work supported National Institutes Coordinated efforts spanning decade yielded vast                             Health grant 1R03TW008926-01, ANPCyT-PICT2009-0095,
collection fully sequenced bacteriophages. 600 fully                                CONICET-PIP2011-0222.

                      References                               5.   Tanji Y, Furukawa C, Na S-H, Hijikata T, Miyanaga       8.  Court DL, Sawitzke JA, Thomason LC. Genetic
                                                                    K, Unno H. Escherichia coli detection GFP-labeled        engineering using homologous recombination. Annu
1.   Hendrix RW, Lawrence JG, Hatfull GF, Casjens S.
                                                                    lysozyme-inactivated T4 bacteriophage. J Biotechnol         Rev Genet 2002; 36:361-88; PMID:12429697; http://
     origins ongoing evolution viruses. Trends
                                                                    2004; 114:11-20; PMID:15464594; http://dx.doi.org/          dx.doi.org/10.1146/annurev.genet.36.061102.093104
     Microbiol 2000; 8:504-8; PMID:11121760; http://dx.
                                                                    10.1016/j.jbiotec.2004.05.011                           9. Copeland NG, Jenkins NA, Court DL. Recombineer-
     doi.org/10.1016/S0966-842X(00)01863-1
                                                               6.   Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG,            ing: powerful new tool mouse functional
2.   BrÃ¼ssow H, Hendrix RW. Phage Genomics: Small                                                                     Court DL. efficient recombination chro-       genomics. Nat Rev Genet 2001; 2:769-79; PMID:
     Beautiful. Cell 2002; 108:13-6; PMID:11792317
                                                                    mosome engineering Escherichia coli. Proc Natl           11584293; http://dx.doi.org/10.1038/35093556
3.   Jacobs WR Jr. Mycobacterium tuberculosis:                                                                     Acad Sci USA 2000; 97:5978-83; PMID:10811905;           10. Swaminathan S, Ellis HM, Waters LS, Yu D, Lee EC,
     Genetically Intractable Organism.  Hatfull GF,
                                                                    http://dx.doi.org/10.1073/pnas.100127597                    Court DL, et al. Rapid engineering bacterial artificial
     Jacobs Jr. WR, eds. Molecular Genetics Myco-
                                                               7.   Ellis HM, Yu D, DiTizio T, Court DL. High efficiency        chromosomes using oligonucleotides. Genesis 2001; 29:
     bacteria. Washington, DC: ASM Press, 2000:1-16.
                                                                    mutagenesis, repair, engineering chromosomal         14-21; PMID:11135458; http://dx.doi.org/10.1002/
4.   Sarkis GJ, Jacobs WR, Hatfulll GF. L5 luciferase
                                                                    DNA using single-stranded oligonucleotides. Proc Natl       1526-968X(200101)29:1,14::AID-GENE1001.3.0.
     reporter mycobacteriophages: sensitive tool                                                                     Acad Sci USA 2001; 98:6742-6; PMID:11381128;                2-X
     detection assay live mycobacteria. Mol Microbiol
                                                                    http://dx.doi.org/10.1073/pnas.121164898
     1995; 15:1055-67; PMID:7623662; http://dx.doi.org/
     10.1111/j.1365-2958.1995.tb02281.x




12                                                                                 Bacteriophage                                                                   Volume 2 Issue 1
 11. Sarov M, Schneider S, Pozniakovski  Roguev            27. PÃ¢ques F, Haber JE. Multiple pathways recombina-        42. Morris P, Marinelli LJ, Jacobs-Sera D, Hendrix RW,
    Ernst S, Zhang Y, et al. recombineering pipeline        tion induced double-strand breaks Saccharomyces          Hatfull GF. Genomic characterization mycobacter-
    functional genomics applied Caenorhabditis elegans.        cerevisiae. Microbiol Mol Biol Rev 1999; 63:349-404;           iophage Giles: evidence phage acquisition host
    Nat Methods 2006; 3:839-44; PMID:16990816;                    PMID:10357855                                                  DNA illegitimate recombination. J Bacteriol 2008;
    http://dx.doi.org/10.1038/nmeth933                        28. Smith GR. Homologous recombination near far                190:2172-82; PMID:18178732; http://dx.doi.org/10.
12. Zhang Y, Buchholz F, Muyrers JP, Stewart AF. new            DNA breaks: alternative roles contrasting             1128/JB.01657-07
    logic DNA engineering using recombination              views. Annu Rev Genet 2001; 35:243-74; PMID:               43. Pham TT, Jacobs-Sera D, Pedulla ML, Hendrix RW,
    Escherichia coli. Nat Genet 1998; 20:123-8; PMID:             11700284; http://dx.doi.org/10.1146/annurev.genet.35.          Hatfull GF. Comparative genomic analysis myco-
    9771703; http://dx.doi.org/10.1038/2417                       102401.090509                                                  bacteriophage Tweety: evolutionary insights 
13. Muyrers JP, Zhang Y, Testa G, Stewart AF. Rapid           29. Maresca M, Erler  Fu J, Friedrich  Zhang Y,                struction compatible site-specific integration vectors
    modification bacterial artificial chromosomes ET-       Stewart AF. Single-stranded heteroduplex intermediates         mycobacteria. Microbiology 2007; 153:2711-23;
    recombination. Nucleic Acids Res 1999; 27:1555-7;             lambda Red homologous recombination. BMC Mol                PMID:17660435;          http://dx.doi.org/10.1099/mic.0.
    PMID:10037821; http://dx.doi.org/10.1093/nar/27.6.            Biol 2010; 11:54; PMID:20670401; http://dx.doi.org/            2007/008904-0
    1555                                                          10.1186/1471-2199-11-54                                    44. Hatfull GF, Pedulla ML, Jacobs-Sera D, Cichon PM,
14. Datsenko KA, Wanner BL. step inactivation          30. Mosberg JA, Lajoie MJ, Church GM. Lambda red                   Foley  Ford  et al. Exploring mycobacter-
    chromosomal genes Escherichia coli K-12 using              recombineering Escherichia coli occurs            iophage metaproteome: phage genomics edu-
    PCR products. Proc Natl Acad Sci USA 2000; 97:                fully single-stranded intermediate. Genetics 2010; 186:        cational platform. PLoS Genet 2006; 2:e92;
    6640-5; PMID:10829079; http://dx.doi.org/10.1073/             791-9; PMID:20813883; http://dx.doi.org/10.1534/               PMID:16789831; http://dx.doi.org/10.1371/journal.
    pnas.120163297                                                genetics.110.120782                                            pgen.0020092
15. Piuri M, Hatfull GF. peptidoglycan hydrolase motif      31. Gottesman MM, Gottesman  Gottesman S, Gellert           45. Pedulla ML, Ford  Houtz JM, Karthikeyan T,
    mycobacteriophage TM4 tape measure                 M. Characterization bacteriophage lambda reverse            Wadsworth C, Lewis JA, et al. Origins highly mosaic
    protein promotes efficient infection stationary            Escherichia coli phage carrying unique set             mycobacteriophage genomes. Cell 2003; 113:171-82;
    phase cells. Mol Microbiol 2006; 62:1569-85; PMID:            host-derived recombination functions. J Mol Biol            PMID:12705866; http://dx.doi.org/10.1016/S0092-
    17083467;        http://dx.doi.org/10.1111/j.1365-2958.       1974; 88:471-87; PMID:4616090; http://dx.doi.org/              8674(03)00233-2
    2006.05473.x                                                  10.1016/0022-2836(74)90496-3                               46. van Kessel JC, Hatfull GF. Mycobacterial recombineer-
16. Ranallo RT, Barnoy S, Thakkar S, Urick T, Venkatesan      32. Iyer LM, Koonin EV, Aravind L. Classification              ing. Methods Mol Biol 2008; 435:203-15; PMID:




Â© 2012 Landes Bioscience.
    MM. Developing live Shigella vaccines using l Red             evolutionary history single-strand annealing            18370078; http://dx.doi.org/10.1007/978-1-59745-
    recombineering. FEMS Immunol Med Microbiol                    proteins, RecT, Redbeta, ERF RAD52. BMC                    232-8_15
    2006; 47:462-9; PMID:16872384; http://dx.doi.org/             Genomics 2002; 3:8; PMID:11914131; http://dx.doi.          47. van Kessel JC, Hatfull GF. Efficient point mutagenesis
    10.1111/j.1574-695X.2006.00118.x                              org/10.1186/1471-2164-3-8                                      mycobacteria using single-stranded DNA recombi-
17. Swingle B, Markel E, Costantino N, Bubunenko MG,          33. Hall SD, Kolodner RD. Homologous pairing                   neering: characterization antimycobacterial drug
    Cartinhour S, Court DL. Oligonucleotide recombina-            strand exchange promoted Escherichia coli RecT          targets. Mol Microbiol 2008; 67:1094-107; PMID:
    tion Gram-negative bacteria. Mol Microbiol 2010;           protein. Proc Natl Acad Sci USA 1994; 91:3205-9;               18221264; http://dx.doi.org/10.1111/j.1365-2958.2008.
    75:138-48; PMID:19943907; http://dx.doi.org/10.               PMID:8159725; http://dx.doi.org/10.1073/pnas.91.8.             06109.x
    1111/j.1365-2958.2009.06976.x                                 3205                                                       48. Parish T, Mahenthiralingam E, Draper P, Davis EO,




                             distribute.
18. Pontes MH, Dale C. Lambda red-mediated genetic            34. Noirot P, Kolodner RD. DNA strand invasion pro-                Colston MJ. Regulation inducible acetamidase
    modification insect endosymbiont Sodalis               moted Escherichia coli RecT protein. J Biol Chem            gene Mycobacterium smegmatis. Microbiology 1997;
    glossinidius. Appl Environ Microbiol 2011; 77:1918-           1998; 273:12274-80; PMID:9575178; http://dx.doi.               143:2267-76; PMID:9245815; http://dx.doi.org/10.
    20; PMID:21216910; http://dx.doi.org/10.1128/AEM.             org/10.1074/jbc.273.20.12274                                   1099/00221287-143-7-2267
    02166-10                                                  35. Zhang Y, Muyrers JP, Rientjes J, Stewart AF. Phage         49. Costantino N, Court DL. Enhanced levels lambda
19. Katashkina JI, Hara Y, Golubeva LI, Andreeva IG,              annealing proteins promote oligonucleotide-directed            Red-mediated recombinants mismatch repair
    Kuvaeva TM, Mashko SV. Use lambda Red-                 mutagenesis Escherichia coli mouse ES cells.            mutants. Proc Natl Acad Sci USA 2003; 100:15748-
    recombineering method genetic engineering              BMC Mol Biol 2003; 4:1; PMID:12530927; http://dx.              53; PMID:14673109; http://dx.doi.org/10.1073/pnas.
    Pantoea ananatis. BMC Mol Biol 2009; 10:34; PMID:             doi.org/10.1186/1471-2199-4-1                                  2434959100
    19389224; http://dx.doi.org/10.1186/1471-2199-10-34       36. Datta S, Costantino N, Court DL. set recom-           50. Lopes  Amarir-Bouhram J, Faure G, Petit MA,
20. Kulkarni SK, Stahl FW. Interaction sbcC           bineering plasmids gram-negative bacteria. Gene            Guerois R. Detection novel recombinases     gene Escherichia coli gam gene phage            2006; 379:109-15; PMID:16750601; http://dx.doi.                bacteriophage genomes unveils Rad52, Rad51     lambda. Genetics 1989; 123:249-53; PMID:2531105               org/10.1016/j.gene.2006.04.018                                 Gp2.5 remote homologs. Nucleic Acids Res 2010;
21. Murphy KC. lambda Gam protein inhibits                37. Datta S, Costantino N, Zhou X, Court DL. Identifi-             38:3952-62; PMID:20194117; http://dx.doi.org/10.
    RecBCD binding dsDNA ends. J Mol Biol 2007;                cation analysis recombineering functions           1093/nar/gkq096
    371:19-24; PMID:17583735; http://dx.doi.org/10.               Gram-negative Gram-positive bacteria         51. Marchler-Bauer  Anderson JB, Chitsaz F, Derbyshire
    1016/j.jmb.2007.05.085                                        phages. Proc Natl Acad Sci USA 2008; 105:1626-31;              MK, DeWeese-Scott C, Fong JH, et al. CDD: specific
22. MarsiÄ‡ N, Roje S, Stojiljkovic  Salaj-Smic E,               PMID:18230724;           http://dx.doi.org/10.1073/pnas.       functional annotation Conserved Domain
    Trgovcevic  vivo studies interaction           0709089105                                                     Database. Nucleic Acids Res 2009; 37:D205-10;
    RecBCD enzyme lambda Gam protein. J Bacteriol         38. Swingle B, Bao  Markel E, Chambers  Cartinhour             PMID:18984618; http://dx.doi.org/10.1093/nar/gkn845
    1993; 175:4738-43; PMID:8335632                               S. Recombineering using RecTE Pseudomonas             52. Marinelli LJ, Piuri M, Swigonova  Balachandran 
23. Court R, Cook N, Saikrishnan K, Wigley D.                 syringae. Appl Environ Microbiol 2010; 76:4960-8;              Oldfield LM, van Kessel JC, et al. BRED: simple     crystal structure lambda-Gam protein suggests            PMID:20543050;          http://dx.doi.org/10.1128/AEM.         powerful tool constructing mutant recombinant
    model RecBCD inhibition. J Mol Biol 2007; 371:            00911-10                                                       bacteriophage genomes. PLoS 2008; 3:e3957;
    25-33; PMID:17544443; http://dx.doi.org/10.1016/j.        39. van Kessel JC, Hatfull GF. Recombineering Myco-             PMID:19088849; http://dx.doi.org/10.1371/journal.
    jmb.2007.05.037                                               bacterium tuberculosis. Nat Methods 2007; 4:147-52;            pone.0003957
24. Yu D, Sawitzke JA, Ellis H, Court DL. Recombineer-            PMID:17179933; http://dx.doi.org/10.1038/nmeth996          53. Hsiao CL, Black LW. DNA packaging pathway
    ing overlapping single-stranded DNA oligonucleo-     40. Hatfull GF, Jacobs-Sera D, Lawrence JG, Pope WH,               bacteriophage T4 head assembly. Proc Natl Acad Sci
    tides: testing recombination intermediate. Proc Natl        Russell DA, Ko CC, et al. Comparative genomic                  USA 1977; 74:3652-6; PMID:269421; http://dx.doi.
    Acad Sci USA 2003; 100:7207-12; PMID:12771385;                analysis 60 Mycobacteriophage genomes: genome               org/10.1073/pnas.74.9.3652
    http://dx.doi.org/10.1073/pnas.1232375100                     clustering, gene acquisition, gene size. J Mol Biol    54. VÃ¶lker TA, Kuhn  Showe MK, Bickle TA. Gene 67,
25. Stahl MM, Thomason L, Poteete AR, Tarkowski T,                2010; 397:119-43; PMID:20064525; http://dx.doi.                new, essential bacteriophage T4 head gene codes     Kuzminov  Stahl FW. Annealing vs. invasion               org/10.1016/j.jmb.2010.01.011                                  prehead core component, PIP. II. construction     phage lambda recombination. Genetics 1997; 147:961-       41. Pope WH, Jacobs-Sera D, Russell DA, Peebles CL, Al-            vitro unconditionally lethal mutants     77; PMID:9383045                                              Atrache  Alcoser TA, et al. Expanding diversity          maintenance. J Mol Biol 1982; 161:491-504; PMID:
26. Langston LD, Symington LS. Gene targeting yeast         mycobacteriophages: insights genome architec-          7154088; http://dx.doi.org/10.1016/0022-2836(82)
    initiated independent strand invasions. Proc           ture evolution. PLoS 2011; 6:e16329;                   90403-X
    Natl Acad Sci USA 2004; 101:15392-7; PMID:                    PMID:21298013; http://dx.doi.org/10.1371/journal.
    15489271; http://dx.doi.org/10.1073/pnas.0403748101           pone.0016329




www.landesbioscience.com                                                          Bacteriophage                                                                                       13
 55. MÃ¼ller UR. Enzymatic construction selection         66. Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C,      73. Sampson T, Broussard GW, Marinelli LJ, Jacobs-Sera
    bacteriophage G4 mutants modifications               McAdam RA, et al. Conditionally replicating myco-             D, Ray M, Ko CC, et al. Mycobacteriophages BPs,
    DNA secondary structure J-F intercistronic              bacte